[黑特] 美國FDA專家認為莫德納不符合追加劑條件

dslite10/13 12:09政商關係差就乖乖下去

eduishappy10/13 12:09就是說，不給莫德納廠商賺錢，可能踩到美國政府的地雷

fuyu111210/13 12:09做太好反而少賺的意思？

helba10/13 12:09抗體很高 下去（？

s8104811210/13 12:09不給賺?

autoexecbat10/13 12:11做太好 不能賺?

kusowan10/13 12:11莫德納的mrna劑量比bnt高出很多

michaelkobe10/13 12:12默德納表示：劑量高讓人民少打一點也臭惹嗎QQ

r1397468210/13 12:21藥證呢？

falconer10/13 12:23所以正確的說法是專家認為打莫德納還不需要追加

Zuiho10/13 12:27所以不是mRNA這個技術不能持久 是BNT的問題

tsubasawolfy10/13 12:36路透的原文下面有審查的說出原因

CavendishJr10/13 12:42路透社跟這篇新聞講的一樣

rexqwer10/13 12:55意思就是抗體跟輝瑞比起來還是高很多 這樣還想打追加劑

rexqwer10/13 12:55？ 下去吧

WLR10/13 13:01對接種者好事，對廠商壞事

yayapapa10/13 13:01不就證明BNT真的沒凍頭，但是美國歐盟買了半數BNT回不了

yayapapa10/13 13:01頭

tsubasawolfy10/13 13:10The evidence for Moderna's booster appears to

tsubasawolfy10/13 13:10have "a lot of holes," said Dr. Eric Topol, a

tsubasawolfy10/13 13:10professor of molecular medicine and director of

tsubasawolfy10/13 13:10the Scripps Research Translational Institute in

tsubasawolfy10/13 13:10La Jolla, California, noting that the data

tsubasawolfy10/13 13:10provided was limited and offers no insight into

tsubasawolfy10/13 13:10how the boosters actually perform in people.

tsubasawolfy10/13 13:11"That is fairly short of what Pfizer had from

tsubasawolfy10/13 13:11Israel, where they had the full restoration of

tsubasawolfy10/13 13:11the vaccine effectiveness from the booster,"

tsubasawolfy10/13 13:11Topol said

tsubasawolfy10/13 13:12默德那提供的data不足，無法有效區別第三劑是否真的

tsubasawolfy10/13 13:13有用。輝瑞BNT的以色列結果提供充分證據所以才給

tsubasawolfy10/13 13:15第三劑許可。也因為資料不夠，路透第一段才寫“可

tsubasawolfy10/13 13:15能因為”

donkilu10/13 14:15反正當初劑量就高 可以直接撐到次世代

donkilu10/13 14:16樓上專業 政黑仔整天只會嘴 新聞也沒看清楚

lbowlbow10/13 16:15這純粹只是不需要吧。嬌生不是半年後要再追加一劑

dash00710/13 16:17抗體持久力太強了，終究是小公司出身，尚未領悟商業之道